Human Longevity Announces the Acquisition of DoctorsForMe
SAN DIEGO--(BUSINESS WIRE)--Jan 15, 2020--
Human Longevity, Inc., an innovator in providing data-driven health intelligence and precision health to physicians and patients, announced today the acquisition of DoctorsForMe, Inc. The acquisition now allows clients of Human Longevity to access world-class physicians and services of Mass General, well trusted by patients worldwide as one of the best hospitals in the world.
David Karow, MD, PhD, President and Chief Innovation Officer of Human Longevity, commented, “DoctorsForMe uses Big Data and AI technologies to match a patient with a doctor that perfectly matches the patient’s specific need. The acquisition enables Human Longevity to provide a complete health intelligence solution for our clients from early disease detection to personalized treatment, all with the goal of living a longer, healthier life.”
ABOUT HUMAN LONGEVITY
Human Longevity provides unparalleled, precision health analytics to individuals through the Health Nucleus™ in La Jolla, CA. The Health Nucleus provides an assessment of current and future risk for cardiac, oncologic, metabolic and cognitive diseases and conditions. This is provided via a multi-modal approach, integrating data from an individual’s whole genome, brain and body imaging via MRI, cardiac CT calcium scan, metabolic tests and more, using machine learning and artificial intelligence.
View source version on businesswire.com:https://www.businesswire.com/news/home/20200115005207/en/
CONTACT: Debbie Feinberg, VP of Marketing
Human Longevity, Inc.
KEYWORD: CHINA UNITED STATES NORTH AMERICA ASIA PACIFIC CALIFORNIA
INDUSTRY KEYWORD: PRACTICE MANAGEMENT MANAGED CARE GENERAL HEALTH HEALTH DATA MANAGEMENT TECHNOLOGY OTHER TECHNOLOGY OTHER HEALTH
SOURCE: Human Longevity, Inc.
Copyright Business Wire 2020.
PUB: 01/15/2020 08:00 AM/DISC: 01/15/2020 08:01 AM